Single-dose fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with gynecologic cancers receiving moderately emetogenic chemotherapy regimens
Autor: | Weinstein, C., Jordan, K., Green, S., Khanani, S., Beckford-Brathwaite, E., Vallejos, W., Pong, A., Noga, S.J., Rapoport, B.L. |
---|---|
Zdroj: | In Gynecologic Oncology June 2018 149 Supplement 1:161-162 |
Databáze: | ScienceDirect |
Externí odkaz: |